24 Furthermore, the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease trial, which involved participants with stage 2 to 4 CKD and moderately elevated albuminuria or stage 1 or 2 CKD and severely increased albuminuria, showed a reduction in CV morbidity, most prominently through a reduction in heart failure-related hospitalisations, with finerenone therapy
95% CI: -0.83 to -0.29), sequential exclusion of these studies totally eliminated heterogeneity (I = 0.0%)
Reproductive Biomedicine Online, 59 (2), 255267
The platform royalties represent a recurring revenue stream that is less correlated with any individual products clinical success than milestone and royalty payments from a traditional out-licensing deal
Unsere kostenlosen Peptid-Tools Berechne Dosierungen, finde das passende Peptid, stelle deinen Stack zusammen, vergleiche Peptide oder entdecke unser Lexikon